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mhest pain is a common cause of emer-
gency department presentation in the
United States with about 6 million pa-
tient visits every year (1), and many
ore elective presentations to physician offices. A
mall proportion of these patients go on to the
iagnosis of myocardial infarction, and many in-
ividuals undergo either anatomic or functional
esting for coronary artery disease in the course of
heir evaluation. However, in the management of
hese patients, an assumption is often made that
hest pain is a consequence of an identified coro-
ary stenosis, but considering that both of these
ntities are frequent, there is clearly a possibility
hat the association is coincidental. In patients in
hom chest pain is ongoing, it has been well es-
ablished that the absence of regional wall motion
bnormalities or perfusion defects (2,3) is reassur-
ng in defining the absence of ischemia. However,
schemic memory imaging could potentially be
ery helpful in identifying antecedent chest pain
s having been ischemic, possibly circumventing
ither the performance of more intensive testing
r of the inappropriate management of coinciden-
al coronary disease and noncardiac chest pain. A
umber of markers have been identified in the
athway between the metabolic and functional
onsequences of ischemia, as well as signs of non-
ethal injury that could help to identify whether
ecent pain was cardiac in origin (Table 1).
The simplest of the memory parameters could
e electrocardiographic (ECG) changes and blood
ests. The ECG alterations, such as the T-wave
hanges, are unlikely to be specific; although isch-
From the *Cleveland Clinic, Cleveland, Ohio; †University of Maryland,
Baltimore, Maryland; and the ‡Mount Sinai Medical Center, New York,
New York.mic changes rarely show the combination of pos-
tive T-waves and aVL, positive or isoelectric
hanges in lead I and precordial T-wave inversion
xceeding that seen in lead III (4). In contrast,
iochemical markers are more promising. Isch-
mia modified–albumin reflects albumin that has
inding of fatty acids during ischemia (3), which
educes the ability of albumin to combine with
obalt in the assay. Information from this bio-
arker is incremental to troponin and the ECG
5), but the diagnostic accuracy of the technique
emains suboptimal (6,7), with false positives as-
ociated with circulating lactate (8). Moreover,
he window for testing appears to be relatively
rief, with peak levels occurring at 40 min and
ormalization between 2 and 6 h (9). Likewise,
irect measurement of unbound free fatty acids,
hich is associated with ischemia and increased
ympathetic activity, is difficult to apply, inter-
ered with by heparin, and follows a transient
ime course (10). The assessment of fatty acid
inding proteins, which peaks at 5 to 6 h after
he ischemic event and normalizes in 36 h (11),
ay detect noninfarct ischemia (12), although el-
Table 1. Potential Imaging Substrates for Detection of
Ischemic Memory*
Type of Ischemic
Stunning Imaging Strategy
Endothelial Microbubbles targeted to P-selectin
Myocardial T2 (edema) imaging
Metabolic FFA imaging [SPECT & PET]
FDG [PET]
Annexin-A5 [SPECT]
Mechanical Post-systolic thickening
*In addition, ECG alterations (ischemic changes and other drivers of ECG
memory) and circulatory markers (such as ischemia-modiﬁed albumin, fatty acids,
fatty acid binding proteins, and ultra-sensitive troponin) have been proposed.
ECG electrocardiography; FDG F-18 deoxyglucose; FFA free fatty acid;
PET  positron emission tomography; SPECT  single-photon emission
computed tomography.
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127evation may also reflect renal impairment. Clearly,
highly sensitive troponin assays are able to iden-
tify troponin released from nonlethal injury (13).
Myocardial ischemia leaves a metabolic signa-
ture on the myocardium which may provide a
longer lasting signal of ischemic memory than
myocardial perfusion or regional wall motion ab-
normalities (7). In general, ischemia causes not
only alterations of oxygen supply, but also loading
and hormonal changes and alterations in substrate
delivery. The metabolic response to ischemia has
adaptive and maladaptive components, respec-
tively, a reversal to patterns of fetal metabolism
which favors carbohydrate as a substrate verified
by up-regulation of glucose metabolism on F-18
deoxyglucose (FDG) imaging and overload of the
lipid intermediate pathways leading to a reduction
of fatty acid uptake and metabolism (14). For im-
aging of the latter process, branched chain fatty
acids have been found to be more suitable meta-
bolic markers than straight chain fatty acids,
which rapidly release the radiolabel and cause im-
age degradation. Radiolabeled BMIPP (-methyl-
p-iodophenyl-pentadecanoic acid) has been the
most widely studied agent; regional decreases in
the tracer uptake represent reduced fatty acid up-
take and metabolism, consistent with metabolic
stunning, in unstable angina and following exer-
cise-induced ischemia. These alterations as a con-
sequence to myocardial ischemia have been corre-
lated with the degree of changes in stress
perfusion, wall motion abnormalities, and coro-
nary stenoses (15), and may persist for more than
24 h after the initial chest pain episode. The
technique has also been used for identification of
vasospastic angina (16). Indeed disturbances of
BMIPP correlate with reductions of coronary flow
reserve (17). An alternative approach is to use in-
creased uptake of FDG as a marker of ischemia
in the fasting state. Patients with positive FDG
scans correlate with stress-induced disturbances of
flow, and these changes are persistent for more
than an hour after stress testing (18). In addition
to the metabolic alterations, ischemia induces a
reversible cascade of apoptotic programmed death
process with caspase-3 upregulation in myocytes,
which results in continuous expression of phos-
phatidylserine on to cell surface lasting for at least
6 h (19). It has been proposed that radiolabeledannexin A5 that avidly binds to phosphatidylser-
ine may be the marker of ischemic memory.
A completely different molecular strategy has
been pursued to demonstrate ischemia induced
reversible endothelial changes using ultrasound
contrast agents targeted to P-selectin (20). These
microbubbles identify sites of endothelial up-regula-
tion of adhesion molecules which persist after the
resolution of ischemia. Animal studies of the phe-
nomenon using intravital microscopy have shown
increased signal for an hour after reperfusion. The
deleterious effects of ischemia on the endothelium
may result in substantial changes in vascular perme-
ability and myocardial edema may occur before the
onset of irreversible ischemic injury (21). Such tissue
characteristic changes may be detected using T2-
weighted cardiac magnetic resonance, and may serve
as the potential markers for ischemic memory.
Myocardial stunning, evidenced as post-isch-
emic dysfunction, has been described after posi-
tive stress testing (22), and is therefore a potential
marker of ischemic memory. Strain imaging has
the attraction of being able to identify subtle
changes of mechanical function as well as being
inherently quantitative, therefore minimizing vari-
ations between observers. Indeed, diastolic strain
is a quantitative marker of ischemia during stress
echocardiography, as might be expected from the
energy intensity of the myocardial relaxation pro-
cess (23). Post-systolic thickening, evidenced as
ongoing myocardial contraction after aortic valve
closure, should be distinguished from stunning on
the basis of preserved systolic wall motion. Two
important studies have facilitated our understand-
ing of this. In the initial animal model (24), isch-
emia was induced by 5 and 15 min coronary oc-
clusion and dobutamine stress in the setting of a
non–flow limiting stenosis. This study showed
preservation of disturbed contraction of more than
2 h in the setting of a 15 min occlusion, whereas
the post-systolic contraction remained abnormal
for 30 min, even after 5 min of ischemia. The ex-
tension of this observation (25), examined a 2
min occlusion with normalization of systolic pa-
rameters despite ongoing disturbance of the post-
systolic index for 10 to 20 min after the ischemia.
Clearly, there is a balance between the duration
of ischemia and the duration of the abnormal sig-
nal which requires further elucidation. Some cau-
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 1 , 2 0 1 2
J A N U A R Y 2 0 1 2 : 1 2 6 – 8
Marwick et al.
Editor’s Page
128tion needs to be applied to the signal, as it may a
finding in normal myocardium, and the magni-
tude of the signal and its occurrence in the setting
of subnormal strain are usually used as markers to
distinguish pathologic from normal post-systolic
thickening (26).
A variety of options are becoming available for
the detection of ischemic memory. To what ex-
tent these applications will be feasible remains to
be seen. Although biomarkers would have the at-tion to exercise stress testing. J Am
Coll Cardiol 2006;48:2482–4.
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imaging of exercise
dial ischemia withthose that are sensitive may be influenced by
other processes such as left ventricle hypertrophy
and other sources of muscle injury. Although
both positron emission tomography and cardiac
magnetic resonance approaches are attractive, ac-
cess to these modalities will limit their utility in
daily practice. It seems likely that the echocardio-
graphic or single-photon emission computed to-
mography approaches will be most applicable, and
the sustained signal from the latter may make it atraction of feasibility, some lack sensitivity and more promising approach.R E F E R E N C E S
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